69 related articles for article (PubMed ID: 7530253)
21. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
Fiscella M; Ullrich SJ; Zambrano N; Shields MT; Lin D; Lees-Miller SP; Anderson CW; Mercer WE; Appella E
Oncogene; 1993 Jun; 8(6):1519-28. PubMed ID: 8502477
[TBL] [Abstract][Full Text] [Related]
22. IGF binding proteins and their functions.
Clemmons DR
Mol Reprod Dev; 1993 Aug; 35(4):368-74; discussion 374-5. PubMed ID: 7691098
[TBL] [Abstract][Full Text] [Related]
23. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF
Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity.
Brinkman A; Kortleve DJ; Zwarthoff EC; Drop SL
Mol Endocrinol; 1991 Jul; 5(7):987-94. PubMed ID: 1719384
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation.
Abu Shehab M; Iosef C; Wildgruber R; Sardana G; Gupta MB
Endocrinology; 2013 Mar; 154(3):1130-43. PubMed ID: 23354097
[TBL] [Abstract][Full Text] [Related]
26. The role of glycosylation in the action of IGFBP-3.
Firth SM; Baxter RC
Prog Growth Factor Res; 1995; 6(2-4):223-9. PubMed ID: 8817665
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence.
Jones JI; Gockerman A; Busby WH; Wright G; Clemmons DR
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10553-7. PubMed ID: 7504269
[TBL] [Abstract][Full Text] [Related]
28. Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity.
Shen F; Wu M; Ross JF; Miller D; Ratnam M
Biochemistry; 1995 Apr; 34(16):5660-5. PubMed ID: 7727426
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3.
Firth SM; Baxter RC
J Endocrinol; 1999 Mar; 160(3):379-87. PubMed ID: 10076184
[TBL] [Abstract][Full Text] [Related]
30. Modulation of human IGF binding protein-3 activity by structural modification.
Baxter RC; Firth SM
Prog Growth Factor Res; 1995; 6(2-4):215-22. PubMed ID: 8817664
[TBL] [Abstract][Full Text] [Related]
31. The in vivo phosphorylation and glycosylation of human insulin-like growth factor-binding protein-5.
Graham ME; Kilby DM; Firth SM; Robinson PJ; Baxter RC
Mol Cell Proteomics; 2007 Aug; 6(8):1392-405. PubMed ID: 17496250
[TBL] [Abstract][Full Text] [Related]
32. Identification and mutational analysis of the glycosylation sites of human keratin 18.
Ku NO; Omary MB
J Biol Chem; 1995 May; 270(20):11820-7. PubMed ID: 7538124
[TBL] [Abstract][Full Text] [Related]
33. Effects of glycosylation of the residue at position 14 in ovine angiotensinogen on the human renin reaction.
Inui Y; Orihashi T; Nakagawa T; Ebihara A; Suzuki F; Nakamura Y
Biosci Biotechnol Biochem; 1998 Aug; 62(8):1612-4. PubMed ID: 9757569
[TBL] [Abstract][Full Text] [Related]
34. Cellular phosphorylation of an acidic proline-rich protein, PRP1, a secreted salivary phosphoprotein.
Drzymala L; Castle A; Cheung JC; Bennick A
Biochemistry; 2000 Feb; 39(8):2023-31. PubMed ID: 10684652
[TBL] [Abstract][Full Text] [Related]
35. Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells.
Germann UA; Chambers TC; Ambudkar SV; Licht T; Cardarelli CO; Pastan I; Gottesman MM
J Biol Chem; 1996 Jan; 271(3):1708-16. PubMed ID: 8576173
[TBL] [Abstract][Full Text] [Related]
36. Serine 113 is the site of receptor-mediated phosphorylation of the Dictyostelium G protein alpha-subunit G alpha 2.
Chen MY; Devreotes PN; Gundersen RE
J Biol Chem; 1994 Aug; 269(33):20925-30. PubMed ID: 8063709
[TBL] [Abstract][Full Text] [Related]
37. PDZK1 binding and serine phosphorylation regulate subcellular trafficking of organic anion transport protein 1a1.
Choi JH; Murray JW; Wolkoff AW
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G384-93. PubMed ID: 21183661
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of the oncofetal variant of the human bile salt-dependent lipase. identification of phosphorylation site and relation with secretion process.
Verine A; Le Petit-Thevenin J; Panicot-Dubois L; Valette A; Lombardo D
J Biol Chem; 2001 Apr; 276(15):12356-61. PubMed ID: 11148205
[TBL] [Abstract][Full Text] [Related]
39. Mutation of serine 90 to glutamic acid mimics phosphorylation of bovine prolactin.
Maciejewski PM; Peterson FC; Anderson PJ; Brooks CL
J Biol Chem; 1995 Nov; 270(46):27661-5. PubMed ID: 7499231
[TBL] [Abstract][Full Text] [Related]
40. Construction of a hepatocellular carcinoma cell line that stably expresses stathmin with a Ser25 phosphorylation site mutation.
Du J; Tao ZH; Li J; Liu YK; Gan L
Genet Mol Res; 2015 Oct; 14(4):12111-7. PubMed ID: 26505358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
